|
1
|
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
|
Br J Haematol
|
1996
|
1.02
|
|
2
|
Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
|
Leukemia
|
2005
|
0.96
|
|
3
|
A new staging system for multiple myeloma based on the number of S-phase plasma cells.
|
Blood
|
1995
|
0.91
|
|
4
|
Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
|
Pathol Biol (Paris)
|
1999
|
0.87
|
|
5
|
Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. Castelano-Leonés (Spain) Cooperative Group for the Study of Monoclonal Gammopathies.
|
Br J Haematol
|
1995
|
0.85
|
|
6
|
Prognostic value of S-phase cells in AML patients.
|
Br J Haematol
|
1995
|
0.81
|
|
7
|
Coumarin prophylaxis for fulminant purpura syndrome due to homozygous protein C deficiency.
|
Lancet
|
1985
|
0.76
|
|
8
|
Cytogenetic evidence of involvement of an early progenitor myeloid cell in 4;11 translocation-associated acute leukemia.
|
Cancer Genet Cytogenet
|
1991
|
0.75
|
|
9
|
[High cardiac output in myeloma patients. Its prevalence and clinical characteristics. The Castile-León Cooperative Group for the Study of Monoclonal Gammapathies].
|
Med Clin (Barc)
|
1997
|
0.75
|
|
10
|
[The hematologist and the hematology and hemotherapy specialty in general county hospitals].
|
Sangre (Barc)
|
1995
|
0.75
|
|
11
|
Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon.
|
Haematologica
|
2001
|
0.75
|
|
12
|
[Simple rapid test for assaying ristocetin cofactor].
|
Sangre (Barc)
|
1982
|
0.75
|
|
13
|
[Congenital acute megakaryoblastic leukemia associated with trisomy 21].
|
Sangre (Barc)
|
1990
|
0.75
|
|
14
|
[Inhibitors suppression in hemophilia A with continued treatment of factor VIII].
|
Sangre (Barc)
|
1982
|
0.75
|
|
15
|
[Chronic granulocytic leukemia in childhood].
|
Rev Clin Esp
|
1990
|
0.75
|
|
16
|
High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia.
|
Semin Oncol
|
1987
|
0.75
|
|
17
|
[High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia].
|
Sangre (Barc)
|
1987
|
0.75
|